Login / Signup

[Primary Extranodal Diffuse Large B-Cell Lymphoma in the Rituximab Era: a Single-Center Retrospective Analysis].

Lan YangLi-Xia CaoHui-Juan RenYan-Qiu Han
Published in: Zhongguo shi yan xue ye xue za zhi (2024)
Patients with primary extranodal source DLBCL are more common in gastrointestinal involvement, and the overall prognosis is worse than that of patients with lymph node origin. NCCN-IPI score is an important independent adverse prognostic factor for predicting overall survival and progression-free survival in patients with primary extranodal diffuse large B-cell lymphoma.
Keyphrases